Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease

被引：0

作者：

S. M. Ragsdale ^{[1
]}

J. M. Radovich ^{[2
]}

I. I. Coiduras ^{[3
]}

W. V. McCall ^{[1
]}

S. C. Grant ^{[4
]}

C. Lee ^{[2
]}

A. Wilber ^{[3
]}

机构：

[1] Department of Psychology; Program in Neuroscience; Florida State University,Department of Chemical & Biochemical Engineering, FAMU

[2] Florida State University,FSU College of Engineering

[3] Florida State University,CIMAR, National High Magnetic Field Laboratory

[4] Department of Psychiatry and Health Behavior; Medical College of Georgia; Augusta University,Department of Biomedical Sciences; Program in Neuroscience; College of Medicine

[5] Florida State University,undefined

来源：

npj Biological Timing and Sleep | / 2卷 / 1期

关键词：

D O I：

10.1038/s44323-025-00025-5

中图分类号：

学科分类号：

摘要：

We examine the relationship between sleep, glymphatics and Alzheimer’s disease (AD), and recent work questioning glymphatic clearance during sleep. We highlight a need for understanding glymphatic and/or other mechanism of clearance during sleep, and review glymphatic flow measurement methods. Further, we explore dual orexin receptor antagonists (DORAs) potential to mitigate AD sleep disturbances and enhance clearance. Further research could elucidate a linkage between DORAs, improved sleep and reducing AD pathophysiology.

引用

共 50 条

[31] Orexin and Alzheimer's Disease: A New Perspective
Um, Yoo Hyun
Lim, Hyun Kook
PSYCHIATRY INVESTIGATION, 2020, 17 (07) : 621 - 626
[32] Hypocretin (orexin) loss in Alzheimer's disease
Fronczek, Rolf
van Geest, Sarita
Frolich, Marijke
Overeem, Sebastiaan
Roelandse, Freek W. C.
Lammers, Gert Jan
Swaab, Dick F.
NEUROBIOLOGY OF AGING, 2012, 33 (08) : 1642 - 1650
[33] Hypocretin(orexin) pathology in Alzheimer's disease
Thomas C Thannickal
World Journal of Neurology, 2015, 5 (03) : 64 - 67
[34] Orexin, orexin receptor antagonists and central cardiovascular control
Carrive, Pascal
FRONTIERS IN NEUROSCIENCE, 2013, 7
[35] NMDA receptor antagonists - A new therapeutic approach for Alzheimer's disease
Farlow, MR
GERIATRICS-US, 2004, 59 (06): : 22 - 27
[36] The orexin story and orexin receptor antagonists for the treatment of insomnia
Muehlan, Clemens
Roch, Catherine
Vaillant, Cedric
Dingemanse, Jasper
JOURNAL OF SLEEP RESEARCH, 2023, 32 (06)
[37] Novel therapeutics for Alzheimer's disease
Tanzi, Rudolph E.
NEUROTHERAPEUTICS, 2008, 5 (03) : 377 - 380
[38] Splicing therapeutics for Alzheimer's disease
Wasser, Catherine R.
Herz, Joachim
EMBO MOLECULAR MEDICINE, 2016, 8 (04) : 308 - 310
[39] Frontiers in Alzheimer's disease therapeutics
Stone, Jeremy G.
Casadesus, Gemma
Gustaw-Rothenberg, Kasia
Siedlak, Sandra L.
Wang, Xinglong
Zhu, Xiongwei
Perry, George
Castellani, Rudy J.
Smith, Mark A.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (01) : 9 - 23
[40] Emerging Therapeutics for Alzheimer's Disease
Chiang, Karen
Koo, Edward H.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 : 381 - 405

← 1 2 3 4 5 →